cbdMD agrees to buy Twinlab brands in assignment-for-benefit-of-creditors process
YCBD•cbdMD to buy Twinlab operating assets and brands
cbdMD signed a definitive asset purchase agreement to buy Twinlab’s operating assets and brands through an assignment for the benefit of creditors process.
The transaction requires court approval and is intended to provide an orderly resolution of legacy obligations while keeping products and customer relationships operating.
The deal would shift the brands to a new owner, expanding cbdMD beyond hemp while lifting combined trailing 12-month revenue to about $30 million.
